About the Biotech Company Enrichment Tool
The Tnuki Biotech Company Enrichment Tool turns a plain list of biotech and pharma companies into a research-grade table from a single paste, with therapeutic area, modality, pipeline and lead programs, clinical-trial activity, funding and investors, recent publications, and the right scientific or commercial contact. It reads across 40+ live life-sciences databases (PubMed, ClinicalTrials.gov, NIH RePORTER, openFDA, Semantic Scholar, and more), so the data reflects what is actually happening in each company's science, not a stale directory entry.
Data generic enrichment tools can't give you
Apollo, ZoomInfo, and Clay are excellent at firmographics and contact data, but they don't know what phase a company's lead asset is in, which indication it's chasing, or whether it just posted a Phase II readout. For life-sciences sales, BD, and investment teams, that scientific context is the qualifying signal. Tnuki appends it: pipeline stage, modality (cell therapy, ADC, mRNA, small molecule), clinical-trial activity, publications, and regulatory milestones, alongside the standard company and contact fields.
Who uses it
Life-sciences sellers enriching a target account list before outreach. BD teams sizing up potential partners or acquirers. Investors and analysts profiling a portfolio or a competitive set. CRO, CDMO, and lab-tools vendors qualifying which biotechs are funded and far enough along to buy. Anyone who has a list of company names and needs the science and the money behind each one.
How it compares to SciLeads and other life-sciences databases
Directory tools like SciLeads give you a database to search and filter by hand. Tnuki does the research and synthesizes the answer: paste your companies, get a finished table, then ask for anything else: "rank by trial momentum," "draft an intro to each CSO," "flag the ones partnered with big pharma." Already a SciLeads user? Export your list and bring it into Tnuki. You can also try it free or see the full list of data sources.